Ads
related to: relapsing multiple sclerosis treatment- Safety & Side Effects
View Possible Infusion Reactions
For An MS Treatment Option
- Multiple Sclerosis Events
Connect Online Or In-Person
Attend Patient Education Events
- Prescribing Information
Find The Prescribing Information
For An MS Treatment Option
- Real Patient Videos
Watch Videos Of Real Patients And
How They Don't Let MS Define Them
- Doctor Discussion Guide
Use This Guide To Help Aid In
Conversations With Your Doctor
- Contact Patient Support
View Support Program to Help With
Financial & Treatment Assistance
- Safety & Side Effects
Search results
9 celebrities with multiple sclerosis who have opened up about the disease
Yahoo Canada Style· 1 day ago“I knew nothing about the disease, to be honest. I fortunately had a doctor who told me right away...
Diagnosing Multiple Sclerosis: 5 Things to Know
Medscape· 3 days agoIn the United States, nearly 1 million people are living with multiple sclerosis (MS), an immune-mediated inflammatory disease that causes demyelination...
Immunic advances ‘potentially groundbreaking’ MS therapy vidofludimus calcium during Q1
Proactive Investors· 3 days agoImmunic Inc (NASDAQ:IMUX) continued to advance its clinical programs for its lead drug asset,...
Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update
WTNH-TV New Haven· 3 days ago"During the first quarter and subsequent period, we have continued to advance both the phase 2 CALLIPER trial in patients with progressive multiple sclerosis</ ...
Royalty Pharma pays startup $525M for stake in Sanofi MS drug
BioPharma Dive via Yahoo Finance· 2 days agoThe deal gives the company milestone payments and royalties to a medicine, frexalimab, that Sanofi...
Earnings call: Immunic outlines progress and financials for Q1 2024
Investing.com· 3 days agoImmunic, Inc. (NASDAQ: IMUX ) reported a loss in the first quarter of 2024 but showcased progress in...
Researchers make strides in understanding little-known autoimmune myelin-impairing disorder
Medical Xpress· 4 days agoIn a new study published in the Journal of Neurology, Neurosurgery & Psychiatry, the researchers detail the discovery of a way to predict which adult patients will experience a relapsing ...
Clene (NASDAQ:CLNN) Stock Rating Reaffirmed by HC Wainwright
ETF DAILY NEWS· 2 days agoClene (NASDAQ:CLNN – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a report issued on Wednesday, Benzinga reports. They presently have a $7.00 ...
Royalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab - Royalty Pharma (NASDAQ:RPRX)
Benzinga· 2 days agoRoyalty Pharma to highlight the strength of its development-stage pipeline on its first quarter of 2024 financial results call today at 8:00 a.m. NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Royalty ...
FY2025 EPS Estimates for TG Therapeutics, Inc. (NASDAQ:TGTX) Lowered by B. Riley
ETF DAILY NEWS· 7 days agoTG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) – Equities researchers at B. Riley cut their FY2025 earnings estimates for shares of TG Therapeutics in a research report issued on Wednesday ...
Ad
related to: relapsing multiple sclerosis treatment